The pandemic caused hospitals and health centers to postpone elective medical procedures, but what was a little surprising was that even companies that provided services needed to treat severe diseases such as cancer saw a drop in business as the stay-at-home orders went into effect.Investors have been buying the stock in recent weeks, after the company launched a new suite of liquid biopsy tests, enabling the detection of cancer biomarkers from blood samples when tissue specimens of solid tumors are hard to obtain.